Name | 1,2,3,4-Tetrahydro-9-methylcarbazol-4-one |
Synonyms | Ondansetron EP Impurity C (USP RC C) 1,2,3,4-Tetrahydro-9-methylcarbazol-4-one 9-Methyl-1,2,3,4-tetrahydro-4-oxocarbazolt 9-METHYL-1,2,3,9-TETRAHYDRO-CARBAZOL-4-ONE 9-METHYL-1,2,3,4-TETRAHYDRO-4-OXOCARBAZOLE 9-METHYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-4-ONE 9-METHYL-1,2,3,9-TETRAHYDRO-4H-CARBAZOL-4-ONE 9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one 1,2,3,9-TETRAHYDRO-9-METHYL-4H-CARBAZOL-4-ONE 1,2,3,9-Tetrahydro-4H-9-methyl-carbazole-4-one 9-METHYL-1,2.3,4-TETRAHYDRO-4-OXOCARBAZOLE-4-ONE 1,2,3,4a,9,9a‐Hexahydro‐9‐ methyl‐4H‐carbazol‐4‐one |
CAS | 27387-31-1 |
EINECS | 608-096-1 |
InChI | InChI=1/C13H13NO/c1-14-10-6-3-2-5-9(10)13-11(14)7-4-8-12(13)15/h2-3,5-6H,4,7-8H2,1H3 |
InChIKey | HHJUJCWZKJMCLC-UHFFFAOYSA-N |
Molecular Formula | C13H13NO |
Molar Mass | 199.25 |
Density | 1.21±0.1 g/cm3(Predicted) |
Melting Point | 199.0 to 203.0 °C |
Boling Point | 383.5±11.0 °C(Predicted) |
Flash Point | 185.7°C |
Vapor Presure | 4.39E-06mmHg at 25°C |
Appearance | neat |
Color | White to Light yellow |
BRN | 153862 |
Storage Condition | Keep in dark place,Sealed in dry,Room Temperature |
Refractive Index | 1.647 |
Physical and Chemical Properties | White crystalline powder |
Use | Used as an intermediate for the drug anthraxone |
Risk Codes | R36/37/38 - Irritating to eyes, respiratory system and skin. R52/53 - Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment. R25 - Toxic if swallowed |
Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S61 - Avoid release to the environment. Refer to special instructions / safety data sheets. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | UN 2811 6.1 / PGIII |
Use | 1,2,3, 4-tetrahydro-9-methyl-4H-carbazolone (Ondansetron EP impurity C) is used to prepare 5-HT3 regulators, treat and prevent mediated diseases. This product is an impurity of ondansetron. Used as an intermediate of the drug anthractodone |